Increasing Access to Hepatitis C Virus Medications: A Program Model Using Patient Navigators and Specialty Pharmacy to Obtain Prior Authorization Approval

BACKGROUND: Obtaining prior authorization (PA) approval for the new direct-acting antiviral (DAA) hepatitis C medications is time consuming and requires specific expertise. Our primary care-based program treats hepatitis C virus (HCV)-infected patients at an urban academic medical center and employs...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Manag Care Spec Pharm
Autors principals: Vu, Trang M., Toribio, Wilma, Riazi, Farah, Ciprian, Genesis, Gibbs, Nathalia, Giardina, Martha, Camacho, Jocelyn A., Parrella, Korin, Cambe, Joy, Amory, Catherine, Chasan, Rachel, Sigel, Keith M., Weiss, Jeffrey J.
Format: Artigo
Idioma:Inglês
Publicat: Academy of Managed Care Pharmacy 2018
Matèries:
Research Brief
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6862767/
https://ncbi.nlm.nih.gov/pubmed/29578854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18553/jmcp.2018.24.4.329
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars